Compumedics (CMP.AX) Stock Price
Compumedics Price
Revenue has compounded at 2.6% per year over the past 19 years to 60.25 M AUD. Earnings per share have grown at 1.1% per year over the last 19 years. Compumedics's net margin stands at 0.4%, down from 3.6% several years earlier. Analysts set a median price target of 0.82 AUD, implying 240.0% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Compumedics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Compumedics business model & stock analysis
Frequently asked questions about Compumedics
Analysts currently set an average price target of 0.82 AUD for the Compumedics stock (median: 0.82 AUD), implying +240.0 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Compumedics stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Compumedics share trades at 0.15 EUR (0.24 AUD).
The Compumedics share (CMP.AX) is listed on 1 stock exchanges, including: ASX (CMP.AX).
The revenue of Compumedics is 60.25 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Compumedics is 214,000.00 AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Compumedics is currently 240.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Compumedics stock.
The price-to-sales ratio (P/S) of Compumedics is currently 0.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Compumedics stock.
The Eulerpool Quality Score for Compumedics is 3/10.
The ISIN of Compumedics is AU000000CMP2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Compumedics is CMP.AX. The ticker symbol is used to trade Compumedics shares on the stock exchange.
Compumedics stock
Compumedics Peer Group
Compumedics Ticker
Compumedics FIGI
All fundamentals and in-depth analysis of Compumedics
Our stock analysis for Compumedics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compumedics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.